Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
Étienne Becht, Nicolás A. Giraldo, Claire Germain, et al.
Advances in immunology (2016), pp. 95-190
Closed Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Étienne Becht, Nicolás A. Giraldo, Laetitia Lacroix, et al.
Genome biology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 2737
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès‐Fridman, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 717-734
Closed Access | Times Cited: 1885
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautès‐Fridman, Florent Petitprez, Julien Caldéraro, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 6, pp. 307-325
Open Access | Times Cited: 1303
The clinical role of the TME in solid cancer
Nicolás A. Giraldo, Rafael Sanchez‐Salas, J. David Peske, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 45-53
Open Access | Times Cited: 553
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez‐Carmona, Julien Lesage, Didier Cataldo, et al.
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 805-823
Open Access | Times Cited: 488
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
Wolf H. Fridman, Maxime Meylan, Florent Petitprez, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 7, pp. 441-457
Closed Access | Times Cited: 398
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 4, pp. 1361-1369
Open Access | Times Cited: 371
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Jörg Wischhusen, Ignacio Melero, Wolf H. Fridman
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 365
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
Catherine Sautès‐Fridman, Myriam Lawand, Nicolás A. Giraldo, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 310
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
Nicolás A. Giraldo, Étienne Becht, Yann Vano, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 15, pp. 4416-4428
Open Access | Times Cited: 302
Topography of cancer-associated immune cells in human solid tumors
Jakob Nikolas Kather, Meggy Suarez‐Carmona, Pornpimol Charoentong, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 251
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Fabienne Maibach, Hassan Sadozai, S. Morteza Seyed Jafari, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 237
Rationale for anti-GITR cancer immunotherapy
Deborah A. Knee, Becker Hewes, Jennifer L. Brogdon
European Journal of Cancer (2016) Vol. 67, pp. 1-10
Open Access | Times Cited: 203
Development of PARP and Immune-Checkpoint Inhibitor Combinations
Ross Stewart, Patrick G. Pilié, Timothy A. Yap
Cancer Research (2018) Vol. 78, Iss. 24, pp. 6717-6725
Open Access | Times Cited: 189
Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
Florent Peyraud, Antoîne Italiano
Cancers (2020) Vol. 12, Iss. 6, pp. 1502-1502
Open Access | Times Cited: 181
The multifaceted immune regulation of bladder cancer
Anna K. Schneider, Mathieu F. Chevalier, Laurent Derré
Nature Reviews Urology (2019) Vol. 16, Iss. 10, pp. 613-630
Closed Access | Times Cited: 154
Functional states of myeloid cells in cancer
Lilian van Vlerken-Ysla, Yulia Y. Tyurina, Valerian E. Kagan, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 490-504
Open Access | Times Cited: 114
The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
César U. Monjarás-Ávila, Ana C. Lorenzo‐Leal, Ana C. Luque-Badillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7946-7946
Open Access | Times Cited: 48
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside
Florent Peyraud, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100546-100546
Closed Access | Times Cited: 2
Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases
Benjamin Frey, Michael Rückert, Lisa Deloch, et al.
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 231-248
Closed Access | Times Cited: 159
Intratumoral HPV16-Specific T Cells Constitute a Type I–Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer
Marij J.P. Welters, Wenbo Ma, Saskia J. Santegoets, et al.
Clinical Cancer Research (2017) Vol. 24, Iss. 3, pp. 634-647
Open Access | Times Cited: 150
Cancer immune contexture and immunotherapy
Étienne Becht, Nicolás A. Giraldo, Marie‐Caroline Dieu‐Nosjean, et al.
Current Opinion in Immunology (2015) Vol. 39, pp. 7-13
Open Access | Times Cited: 146
Genomics and emerging biomarkers for immunotherapy of colorectal cancer
Jakob Nikolas Kather, Niels Halama, Dirk Jaeger
Seminars in Cancer Biology (2018) Vol. 52, pp. 189-197
Open Access | Times Cited: 128
PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors
Emily A. Sloan, Kari L. Ring, Brian C. Willis, et al.
The American Journal of Surgical Pathology (2016) Vol. 41, Iss. 3, pp. 326-333
Closed Access | Times Cited: 127
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics
Zhanhong Wu, Nai‐Kong V. Cheung
Pharmacology & Therapeutics (2017) Vol. 182, pp. 161-175
Open Access | Times Cited: 125
Page 1 - Next Page

Scroll to top